| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 201 | 198 | 184 | 218 | 210 | 198 | 207 | 244 | 218 | 257 | 286 | 313 | |
Growth YoY Revenue Growth YoY% | -2.4 | 7.2 | 15.1 | 2.7 | 4.8 | -0.1 | 13.0 | 12.3 | 3.7 | 29.8 | 37.6 | 28.2 |
| 157 | 170 | 149 | 176 | 181 | 177 | 166 | 201 | 183 | 213 | 209 | 233 | |
| 44 | 28 | 34 | 41 | 30 | 21 | 41 | 43 | 35 | 44 | 76 | 81 | |
OPM OPM% | 21.8 | 14.3 | 18.7 | 19.1 | 14.2 | 10.7 | 19.9 | 17.8 | 15.9 | 17.3 | 26.8 | 25.7 |
| 5 | -24 | 4 | 5 | 15 | 12 | 35 | 8 | 16 | 11 | 10 | 8 | |
Interest Expense Interest ExpenseCr | 2 | 2 | 2 | 4 | 1 | 2 | 5 | 3 | 1 | 2 | 1 | 3 |
Depreciation DepreciationCr | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 8 | 9 | 10 | 11 |
PBT PBTCr | 40 | -4 | 30 | 36 | 36 | 23 | 63 | 41 | 41 | 45 | 75 | 75 |
| 11 | 1 | 8 | 10 | 11 | 7 | 19 | 12 | 16 | 8 | 24 | 22 | |
| 29 | -5 | 22 | 26 | 26 | 17 | 44 | 29 | 25 | 37 | 51 | 53 | |
Growth YoY PAT Growth YoY% | -2.4 | -241.9 | 53.9 | -40.3 | -11.3 | 439.1 | 100.6 | 11.3 | -4.0 | 122.2 | 15.8 | 86.6 |
NPM NPM% | 14.5 | -2.5 | 12.0 | 11.8 | 12.3 | 8.4 | 21.4 | 11.7 | 11.3 | 14.4 | 18.0 | 17.0 |
| 2.6 | -0.9 | 2.0 | 2.3 | 2.3 | 1.5 | 4.1 | 2.6 | 2.2 | 3.4 | 4.7 | 4.9 |
| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 201 | 198 | 184 | 218 | 210 | 198 | 207 | 244 | 218 | 257 | 286 | 313 | |
Growth YoY Revenue Growth YoY% | -2.4 | 7.2 | 15.1 | 2.7 | 4.8 | -0.1 | 13.0 | 12.3 | 3.7 | 29.8 | 37.6 | 28.2 |
| 157 | 170 | 149 | 176 | 181 | 177 | 166 | 201 | 183 | 213 | 209 | 233 | |
| 44 | 28 | 34 | 41 | 30 | 21 | 41 | 43 | 35 | 44 | 76 | 81 | |
OPM OPM% | 21.8 | 14.3 | 18.7 | 19.1 | 14.2 | 10.7 | 19.9 | 17.8 | 15.9 | 17.3 | 26.8 | 25.7 |
| 5 | -24 | 4 | 5 | 15 | 12 | 35 | 8 | 16 | 11 | 10 | 8 | |
Interest Expense Interest ExpenseCr | 2 | 2 | 2 | 4 | 1 | 2 | 5 | 3 | 1 | 2 | 1 | 3 |
Depreciation DepreciationCr | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 8 | 9 | 10 | 11 |
PBT PBTCr | 40 | -4 | 30 | 36 | 36 | 23 | 63 | 41 | 41 | 45 | 75 | 75 |
| 11 | 1 | 8 | 10 | 11 | 7 | 19 | 12 | 16 | 8 | 24 | 22 | |
| 29 | -5 | 22 | 26 | 26 | 17 | 44 | 29 | 25 | 37 | 51 | 53 | |
Growth YoY PAT Growth YoY% | -2.4 | -241.9 | 53.9 | -40.3 | -11.3 | 439.1 | 100.6 | 11.3 | -4.0 | 122.2 | 15.8 | 86.6 |
NPM NPM% | 14.5 | -2.5 | 12.0 | 11.8 | 12.3 | 8.4 | 21.4 | 11.7 | 11.3 | 14.4 | 18.0 | 17.0 |
| 2.6 | -0.9 | 2.0 | 2.3 | 2.3 | 1.5 | 4.1 | 2.6 | 2.2 | 3.4 | 4.7 | 4.9 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 547 | 798 | 815 | 899 | 689 | 577 | 747 | 752 | 770 | 810 | 927 | 1,074 |
Growth Revenue Growth% | 34.3 | 46.0 | 2.0 | 10.3 | -23.3 | -16.3 | 29.5 | 0.6 | 2.5 | 5.1 | 14.5 | 24.9 |
| 391 | 596 | 618 | 741 | 566 | 471 | 629 | 634 | 620 | 683 | 763 | 838 | |
| 156 | 203 | 197 | 158 | 123 | 107 | 118 | 117 | 151 | 127 | 164 | 236 | |
OPM OPM% | 28.5 | 25.4 | 24.2 | 17.5 | 17.9 | 18.5 | 15.8 | 15.6 | 19.6 | 15.7 | 17.7 | 22.0 |
| 24 | 13 | -8 | 38 | 26 | 20 | -42 | 18 | 0 | 36 | 71 | 45 | |
Interest Expense Interest ExpenseCr | 19 | 20 | 23 | 4 | 8 | 6 | 5 | 10 | 7 | 8 | 12 | 7 |
Depreciation DepreciationCr | 13 | 20 | 21 | 9 | 13 | 17 | 17 | 19 | 26 | 29 | 33 | 37 |
PBT PBTCr | 148 | 175 | 145 | 182 | 129 | 104 | 54 | 106 | 117 | 126 | 190 | 236 |
| 48 | 63 | 57 | 55 | 34 | 30 | 31 | 29 | 35 | 35 | 55 | 70 | |
PAT PATCr | 100 | 113 | 89 | 127 | 95 | 74 | 23 | 77 | 82 | 90 | 135 | 166 |
Growth PAT Growth% | 63.1 | 12.5 | -21.3 | 42.9 | -24.8 | -22.3 | -68.7 | 231.8 | 6.3 | 10.6 | 49.3 | 44.3 |
NPM NPM% | 18.3 | 14.1 | 10.9 | 14.1 | 13.8 | 12.8 | 3.1 | 10.2 | 10.6 | 11.2 | 14.5 | 15.5 |
| 8.0 | 8.0 | 5.7 | 12.0 | 9.4 | 6.6 | 1.5 | 6.8 | 7.2 | 8.0 | 12.2 | 15.2 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 547 | 798 | 815 | 899 | 689 | 577 | 747 | 752 | 770 | 810 | 927 | 1,074 |
Growth Revenue Growth% | 34.3 | 46.0 | 2.0 | 10.3 | -23.3 | -16.3 | 29.5 | 0.6 | 2.5 | 5.1 | 14.5 | 24.9 |
| 391 | 596 | 618 | 741 | 566 | 471 | 629 | 634 | 620 | 683 | 763 | 838 | |
| 156 | 203 | 197 | 158 | 123 | 107 | 118 | 117 | 151 | 127 | 164 | 236 | |
OPM OPM% | 28.5 | 25.4 | 24.2 | 17.5 | 17.9 | 18.5 | 15.8 | 15.6 | 19.6 | 15.7 | 17.7 | 22.0 |
| 24 | 13 | -8 | 38 | 26 | 20 | -42 | 18 | 0 | 36 | 71 | 45 | |
Interest Expense Interest ExpenseCr | 19 | 20 | 23 | 4 | 8 | 6 | 5 | 10 | 7 | 8 | 12 | 7 |
Depreciation DepreciationCr | 13 | 20 | 21 | 9 | 13 | 17 | 17 | 19 | 26 | 29 | 33 | 37 |
PBT PBTCr | 148 | 175 | 145 | 182 | 129 | 104 | 54 | 106 | 117 | 126 | 190 | 236 |
| 48 | 63 | 57 | 55 | 34 | 30 | 31 | 29 | 35 | 35 | 55 | 70 | |
PAT PATCr | 100 | 113 | 89 | 127 | 95 | 74 | 23 | 77 | 82 | 90 | 135 | 166 |
Growth PAT Growth% | 63.1 | 12.5 | -21.3 | 42.9 | -24.8 | -22.3 | -68.7 | 231.8 | 6.3 | 10.6 | 49.3 | 44.3 |
NPM NPM% | 18.3 | 14.1 | 10.9 | 14.1 | 13.8 | 12.8 | 3.1 | 10.2 | 10.6 | 11.2 | 14.5 | 15.5 |
| 8.0 | 8.0 | 5.7 | 12.0 | 9.4 | 6.6 | 1.5 | 6.8 | 7.2 | 8.0 | 12.2 | 15.2 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 | 11 |
Reserves ReservesCr | 402 | 476 | 526 | 636 | 725 | 798 | 808 | 873 | 957 | 1,040 | 1,182 | 1,280 |
| 267 | 437 | 299 | 207 | 231 | 204 | 233 | 193 | 157 | 172 | 236 | 230 | |
| 50 | 33 | 13 | 38 | 46 | 45 | 29 | 46 | 51 | 37 | 25 | 21 | |
| 762 | 1,023 | 860 | 905 | 1,027 | 1,077 | 1,109 | 1,157 | 1,212 | 1,301 | 1,492 | 1,582 | |
| 471 | 566 | 690 | 693 | 770 | 765 | 777 | 697 | 811 | 824 | 946 | 999 | |
| 291 | 457 | 170 | 211 | 257 | 312 | 332 | 459 | 401 | 477 | 546 | 583 | |
| 762 | 1,023 | 860 | 905 | 1,027 | 1,077 | 1,109 | 1,157 | 1,212 | 1,301 | 1,492 | 1,582 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 | 11 |
Reserves ReservesCr | 402 | 476 | 526 | 636 | 725 | 798 | 808 | 873 | 957 | 1,040 | 1,182 | 1,280 |
| 267 | 437 | 299 | 207 | 231 | 204 | 233 | 193 | 157 | 172 | 236 | 230 | |
| 50 | 33 | 13 | 38 | 46 | 45 | 29 | 46 | 51 | 37 | 25 | 21 | |
| 762 | 1,023 | 860 | 905 | 1,027 | 1,077 | 1,109 | 1,157 | 1,212 | 1,301 | 1,492 | 1,582 | |
| 471 | 566 | 690 | 693 | 770 | 765 | 777 | 697 | 811 | 824 | 946 | 999 | |
| 291 | 457 | 170 | 211 | 257 | 312 | 332 | 459 | 401 | 477 | 546 | 583 | |
| 762 | 1,023 | 860 | 905 | 1,027 | 1,077 | 1,109 | 1,157 | 1,212 | 1,301 | 1,492 | 1,582 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 113 | 289 | 18 | 40 | 47 | 64 | 135 | 34 | 103 | 106 | 139 | |
| -50 | -231 | 50 | -74 | -48 | -47 | -93 | -8 | -83 | -76 | -38 | |
| -40 | -10 | -76 | 17 | -6 | -21 | -24 | -25 | -21 | -30 | -89 | |
Net Cash Flow Net Cash FlowCr | 23 | 48 | -8 | -17 | -8 | -4 | 19 | 2 | -1 | 0 | 11 |
Free Cash Flow Free Cash FlowCr | 100 | 186 | -7 | 2 | -12 | 55 | 63 | -59 | 75 | 33 | 84 |
CFO To PAT CFO To PAT% | 112.8 | 256.9 | 19.9 | 31.5 | 49.0 | 86.5 | 585.8 | 44.7 | 126.0 | 117.3 | 103.0 |
CFO To EBITDA CFO To EBITDA% | 72.5 | 142.8 | 8.9 | 25.3 | 37.9 | 60.0 | 114.5 | 29.3 | 68.3 | 83.6 | 84.6 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 113 | 289 | 18 | 40 | 47 | 64 | 135 | 34 | 103 | 106 | 139 | |
| -50 | -231 | 50 | -74 | -48 | -47 | -93 | -8 | -83 | -76 | -38 | |
| -40 | -10 | -76 | 17 | -6 | -21 | -24 | -25 | -21 | -30 | -89 | |
Net Cash Flow Net Cash FlowCr | 23 | 48 | -8 | -17 | -8 | -4 | 19 | 2 | -1 | 0 | 11 |
Free Cash Flow Free Cash FlowCr | 100 | 186 | -7 | 2 | -12 | 55 | 63 | -59 | 75 | 33 | 84 |
CFO To PAT CFO To PAT% | 112.8 | 256.9 | 19.9 | 31.5 | 49.0 | 86.5 | 585.8 | 44.7 | 126.0 | 117.3 | 103.0 |
CFO To EBITDA CFO To EBITDA% | 72.5 | 142.8 | 8.9 | 25.3 | 37.9 | 60.0 | 114.5 | 29.3 | 68.3 | 83.6 | 84.6 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 1,308 | 1,820 | 2,015 | 1,856 | 1,040 | 1,018 | 798 | 742 | 1,179 | 1,239 | 2,280 | 6,814 |
Price To Earnings Price To Earnings | 15.8 | 22.2 | 34.3 | 15.0 | 10.7 | 14.9 | 53.1 | 10.5 | 15.6 | 14.7 | 17.6 | 42.1 |
Price To Sales Price To Sales | 2.4 | 2.3 | 2.5 | 2.1 | 1.5 | 1.8 | 1.1 | 1.0 | 1.5 | 1.5 | 2.5 | 6.3 |
Price To Book Price To Book | 3.2 | 3.7 | 3.8 | 2.9 | 1.4 | 1.3 | 1.0 | 0.8 | 1.2 | 1.2 | 1.9 | 5.3 |
EV To EBITDA EV To EBITDA | 8.5 | 9.3 | 10.3 | 11.7 | 8.5 | 9.3 | 6.2 | 6.3 | 7.1 | 8.8 | 13.0 | 28.3 |
GPM GPM% | 51.1 | 52.8 | 49.4 | 30.4 | 34.2 | 40.0 | 44.8 | 44.0 | 46.6 | 45.4 | 50.2 | 50.2 |
OPM OPM% | 28.5 | 25.4 | 24.2 | 17.5 | 17.9 | 18.5 | 15.8 | 15.6 | 19.6 | 15.7 | 17.7 | 22.0 |
NPM NPM% | 18.3 | 14.1 | 10.9 | 14.1 | 13.8 | 12.8 | 3.1 | 10.2 | 10.6 | 11.2 | 14.5 | 15.5 |
ROCE ROCE% | 32.5 | 27.9 | 25.9 | 25.1 | 16.2 | 11.8 | 6.3 | 11.8 | 11.6 | 11.8 | 16.6 | 18.9 |
ROE ROE% | 24.3 | 23.2 | 16.5 | 19.6 | 12.9 | 9.2 | 2.8 | 8.7 | 8.4 | 8.6 | 11.3 | 12.9 |
ROA ROA% | 13.2 | 11.0 | 10.3 | 14.0 | 9.3 | 6.9 | 2.1 | 6.6 | 6.7 | 6.9 | 9.0 | 10.5 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 1,308 | 1,820 | 2,015 | 1,856 | 1,040 | 1,018 | 798 | 742 | 1,179 | 1,239 | 2,280 | 6,814 |
Price To Earnings Price To Earnings | 15.8 | 22.2 | 34.3 | 15.0 | 10.7 | 14.9 | 53.1 | 10.5 | 15.6 | 14.7 | 17.6 | 42.1 |
Price To Sales Price To Sales | 2.4 | 2.3 | 2.5 | 2.1 | 1.5 | 1.8 | 1.1 | 1.0 | 1.5 | 1.5 | 2.5 | 6.3 |
Price To Book Price To Book | 3.2 | 3.7 | 3.8 | 2.9 | 1.4 | 1.3 | 1.0 | 0.8 | 1.2 | 1.2 | 1.9 | 5.3 |
EV To EBITDA EV To EBITDA | 8.5 | 9.3 | 10.3 | 11.7 | 8.5 | 9.3 | 6.2 | 6.3 | 7.1 | 8.8 | 13.0 | 28.3 |
GPM GPM% | 51.1 | 52.8 | 49.4 | 30.4 | 34.2 | 40.0 | 44.8 | 44.0 | 46.6 | 45.4 | 50.2 | 50.2 |
OPM OPM% | 28.5 | 25.4 | 24.2 | 17.5 | 17.9 | 18.5 | 15.8 | 15.6 | 19.6 | 15.7 | 17.7 | 22.0 |
NPM NPM% | 18.3 | 14.1 | 10.9 | 14.1 | 13.8 | 12.8 | 3.1 | 10.2 | 10.6 | 11.2 | 14.5 | 15.5 |
ROCE ROCE% | 32.5 | 27.9 | 25.9 | 25.1 | 16.2 | 11.8 | 6.3 | 11.8 | 11.6 | 11.8 | 16.6 | 18.9 |
ROE ROE% | 24.3 | 23.2 | 16.5 | 19.6 | 12.9 | 9.2 | 2.8 | 8.7 | 8.4 | 8.6 | 11.3 | 12.9 |
ROA ROA% | 13.2 | 11.0 | 10.3 | 14.0 | 9.3 | 6.9 | 2.1 | 6.6 | 6.7 | 6.9 | 9.0 | 10.5 |
| Market CapitalizationMkt CapCr | 10,958 | 8,917 | 7,612 | 6,814 | 6,147 | 5,024 | 4,284 |
| Close PriceClose₹ | 696.20 | 967.30 | 269.40 | 640.55 | 377.55 | 1,090.80 | 4,128.40 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 29.30 | 14.46 | 42.09 | 19.62 | 35.52 | 44.67 | |
| Price To SalesPS | 2.27 | 1.71 | 836.51 | 6.34 | 2.69 | 6.99 | 6.86 |
| RevenueRevenueCr | 4,826 | 5,213 | 9 | 1,074 | 2,289 | 719 | 624 |
| Revenue Growth TTMRev Gr TTM% | 17.5% | 11.3% | 55.0% | 24.9% | 10.2% | 39.0% | 47.7% |
| PAT Growth TTMPAT Gr TTM% | 12.8% | 54.3% | -80.3% | 44.3% | 39.0% | 60.2% | 95.7% |
| Market CapitalizationMkt CapCr | 10,958 | 8,917 | 7,612 | 6,814 | 6,147 | 5,024 | 4,284 |
| Close PriceClose₹ | 696.20 | 967.30 | 269.40 | 640.55 | 377.55 | 1,090.80 | 4,128.40 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 29.30 | 14.46 | 42.09 | 19.62 | 35.52 | 44.67 | |
| Price To SalesPS | 2.27 | 1.71 | 836.51 | 6.34 | 2.69 | 6.99 | 6.86 |
| RevenueRevenueCr | 4,826 | 5,213 | 9 | 1,074 | 2,289 | 719 | 624 |
| Revenue Growth TTMRev Gr TTM% | 17.5% | 11.3% | 55.0% | 24.9% | 10.2% | 39.0% | 47.7% |
| PAT Growth TTMPAT Gr TTM% | 12.8% | 54.3% | -80.3% | 44.3% | 39.0% | 60.2% | 95.7% |